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Background: Antiplatelet therapy (APT) with clopidogrel is inconsistently prescribed to patients following coronary artery bypass graft surgery 
(CABG).
Methods: We analyzed frequency and predictors of post-CABG clopidogrel use and clinical outcomes of all cause death from an ongoing 
prospective VA database (Jan 2003 - Dec 2008). We performed multivariable logistic regression to determine predictors of clopidogrel use and its 
adjusted association to mortality.
Results: We identified 967 patients with mean age 62.3 + 0.3 years, hypertension (98.7%), diabetes (45.7%), hyperlipidemia (81.5%), heart failure 
(70.8%), prior-MI (48.6%) and chronic kidney disease (10.9%) who underwent CABG and were discharged on aspirin alone (n = 778) or on aspirin 
and clopidogrel (dual-APT group, n = 189, 19.5%). Mean number of bypasses were 3.1 + 0.03. Multivariable predictors of clopidogrel prescription 
at discharge were number of bypasses (HR = 0.83, 95% CI 0.68 - 1.00), prior percutaneous coronary intervention (PCI, HR = 2.90, 95% CI = 1.85 - 
4.54) and prior stroke (HR = 2.75, 95% CI = 1.34 - 5.68). An acute coronary syndrome presentation (40.3%) was not a predictor of clopidogrel use 
(HR = 1.10, 95% CI = 0.77 - 1.56). On Kaplan-Meir analysis, prescription of dual-APT was not associated with significantly improved survival post-
CABG.
Conclusion: Clopidogrel is infrequently prescribed post-CABG, and is used primarily in patients with prior-PCI and stroke. Dual-APT is not 
associated with a significant survival benefit. 
